Your browser doesn't support javascript.
loading
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.
Saunders, Philippa M; Pymm, Phillip; Pietra, Gabriella; Hughes, Victoria A; Hitchen, Corinne; O'Connor, Geraldine M; Loiacono, Fabrizio; Widjaja, Jacqueline; Price, David A; Falco, Michela; Mingari, Maria Cristina; Moretta, Lorenzo; McVicar, Daniel W; Rossjohn, Jamie; Brooks, Andrew G; Vivian, Julian P.
Affiliation
  • Saunders PM; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Pymm P; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia Australian Research Council Centre of Excellence in Advanced Molecular Imaging,
  • Pietra G; Department of Experimental Medicine, University of Genova, 16132 Genoa, Italy IRCCS AOU San Martino-IST (National Institute for Cancer Research), 16132 Genoa, Italy.
  • Hughes VA; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia Australian Research Council Centre of Excellence in Advanced Molecular Imaging,
  • Hitchen C; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  • O'Connor GM; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Loiacono F; IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
  • Widjaja J; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Price DA; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Falco M; IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
  • Mingari MC; Department of Experimental Medicine, University of Genova, 16132 Genoa, Italy IRCCS AOU San Martino-IST (National Institute for Cancer Research), 16132 Genoa, Italy.
  • Moretta L; IRCCS Ospedale Pediatrico Bambino Gesù, 00146 Rome, Italy.
  • McVicar DW; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD 21701.
  • Rossjohn J; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia Australian Research Council Centre of Excellence in Advanced Molecular Imaging,
  • Brooks AG; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia jamie.rossjohn@monash.edu agbrooks@unimelb.edu.au julian.vivian@monash.edu.
  • Vivian JP; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia Australian Research Council Centre of Excellence in Advanced Molecular Imaging,
J Exp Med ; 213(5): 791-807, 2016 05 02.
Article in En | MEDLINE | ID: mdl-27045007
ABSTRACT
Natural killer (NK) cells play a key role in immunity, but how HLA class I (HLA-I) and killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) polymorphism impacts disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognizing the widest array of HLA-I ligands. These differences were further reflected in functional studies using NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005, and *015 polymorphisms are remote from the KIR3DL1-HLA-I interface, the structures of these three KIR3DL1-HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Histocompatibility Antigens Class I / Receptors, KIR3DL1 Limits: Female / Humans / Male Language: En Journal: J Exp Med Year: 2016 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Histocompatibility Antigens Class I / Receptors, KIR3DL1 Limits: Female / Humans / Male Language: En Journal: J Exp Med Year: 2016 Document type: Article Affiliation country: Australia